SUPRAN BRYAN has filed 3 insider transactions across 1 company since October 2025.
Most recent transaction: a grant/award of 1539 shares of ALNYLAM PHARMACEUTICALS, INC. ($ALNY) on March 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | SUPRAN BRYAN | EVP, CLO and Secretary | A | Common Stock | 1539 | $0.00 | 14,565.0000 | 134,684,000 | 11.81% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | SUPRAN BRYAN | EVP, CLO and Secretary | A | Stock Option (right to buy) | 3381 | $0.00 | 3,381.0000 | 134,684,000 | 9999.99% | 0.00% |
| Oct. 1, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | SUPRAN BRYAN | EVP, CLO and Secretary | A | Common Stock | 13026 | $0.00 | 13,026.0000 | 137,348,000 | 9999.99% | 0.01% |